Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is there a predictive profile for clinical inertia in hypertensive patients? An observational, cross-sectional, multicentre study.
Gil-Guillén V, Orozco-Beltrán D, Márquez-Contreras E, Durazo-Arvizu R, Cooper R, Pita-Fernández S, González-Segura D, Carratalá-Munuera C, Martín de Pablo JL, Pallarés V, Pertusa-Martínez S, Fernández A, Redón J. Gil-Guillén V, et al. Drugs Aging. 2011 Dec 1;28(12):981-92. doi: 10.2165/11596640-000000000-00000. Drugs Aging. 2011. PMID: 22117096 Clinical Trial.
Clinical inertia in poorly controlled elderly hypertensive patients: a cross-sectional study in Spanish physicians to ascertain reasons for not intensifying treatment.
Gil-Guillén V, Orozco-Beltrán D, Carratalá-Munuera C, Márquez-Contreras E, Durazo-Arvizu R, Cooper R, Pertusa-Martínez S, Pita-Fernandez S, González-Segura D, Martin-de-Pablo JL, Pallarés V, Fernández A, Redón J. Gil-Guillén V, et al. Am J Cardiovasc Drugs. 2013 Jun;13(3):213-9. doi: 10.1007/s40256-013-0025-4. Am J Cardiovasc Drugs. 2013. PMID: 23585143 Clinical Trial.
Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study.
Redon J, Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Sanz G, Martin-Moreno JM; ESCARVAL Study Group. Redon J, et al. J Hypertens. 2016 Jun;34(6):1075-83. doi: 10.1097/HJH.0000000000000930. J Hypertens. 2016. PMID: 27074896
Renal function and attributable risk of death and cardiovascular hospitalization in patients with cardiovascular risk factors from a registry-based cohort: the Estudio Cardiovascular Valencia-risk study.
Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, Pita-Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fernandez A, Perez-Navarro AM, Sanchis C, Dominguez-Lucas A, Martin-Moreno JM, Redon J; ESCARVAL STUDY GROUP. Tellez-Plaza M, et al. J Hypertens. 2016 Nov;34(11):2266-73. doi: 10.1097/HJH.0000000000001089. J Hypertens. 2016. PMID: 27584973
Lipid profile, cardiovascular disease and mortality in a Mediterranean high-risk population: The ESCARVAL-RISK study.
Orozco-Beltran D, Gil-Guillen VF, Redon J, Martin-Moreno JM, Pallares-Carratala V, Navarro-Perez J, Valls-Roca F, Sanchis-Domenech C, Fernandez-Gimenez A, Perez-Navarro A, Bertomeu-Martinez V, Bertomeu-Gonzalez V, Cordero A, Pascual de la Torre M, Trillo JL, Carratala-Munuera C, Pita-Fernandez S, Uso R, Durazo-Arvizu R, Cooper R, Sanz G, Castellano JM, Ascaso JF, Carmena R, Tellez-Plaza M; ESCARVAL Study Group. Orozco-Beltran D, et al. PLoS One. 2017 Oct 18;12(10):e0186196. doi: 10.1371/journal.pone.0186196. eCollection 2017. PLoS One. 2017. PMID: 29045483 Free PMC article.
Rationale and methods of the cardiometabolic Valencian study (Escarval-Risk) for validation of risk scales in Mediterranean patients with hypertension, diabetes or dyslipidemia.
Gil-Guillen V, Orozco-Beltran D, Redon J, Pita-Fernandez S, Navarro-Pérez J, Pallares V, Valls F, Fluixa C, Fernandez A, Martin-Moreno JM, Pascual-de-la-Torre M, Trillo JL, Durazo-Arvizu R, Cooper R, Hermenegildo M, Rosado L. Gil-Guillen V, et al. BMC Public Health. 2010 Nov 22;10:717. doi: 10.1186/1471-2458-10-717. BMC Public Health. 2010. PMID: 21092179 Free PMC article.
[In the identification of cardiovascular risk with the SCORE model, could we recommend its calculation interchangeably with total cholesterol or atherogenic index? Concordance between total cholesterol and atherogenic index in the SCORE table].
Gil-Guillén VF, Orozco-Beltrán D, Pita-Fernández S, Carratalá-Munuera C, Redón J, Navarro J, Pallarés V, Pertusa S. Gil-Guillén VF, et al. Rev Esp Cardiol. 2011 May;64(5):421-3. doi: 10.1016/j.recesp.2010.06.001. Epub 2011 Mar 11. Rev Esp Cardiol. 2011. PMID: 21397378 Free article. Spanish.
Trends in mortality from myocardial infarction. A comparative study between Spain and the United States: 1990-2006.
Orozco-Beltran D, Cooper RS, Gil-Guillen V, Bertomeu-Martinez V, Pita-Fernandez S, Durazo-Arvizu R, Carratala-Munuera C, Cea-Calvo L, Bertomeu-Gonzalez V, Seoane-Pillado T, Rosado LE. Orozco-Beltran D, et al. Rev Esp Cardiol (Engl Ed). 2012 Dec;65(12):1079-85. doi: 10.1016/j.recesp.2012.02.026. Epub 2012 Jun 22. Rev Esp Cardiol (Engl Ed). 2012. PMID: 22727798 English, Spanish.
120 results